Table 1.
Mutation | ATP hydrolysis2 (μmol/min/mg) | + LDAO3 (fold increase4) | + DCCD5 (% inhibition) |
---|---|---|---|
Wild type | 0.9 | 3.9 (4.3) | 80 |
R210Q/Q252R | 0.25 | 3.2 (13) | < 5 |
P204T/R210Q/Q252R | 0.2 | 2.5 (12.7) | < 5 |
R210Q/Q252K | 0.5 | 2.4 (4.8) | < 5 |
P204T/R210Q/Q252K | 0.35 | 1.75 (5) | < 5 |
R210Q | 0.2 | 1.45 (7.2) | 22 |
Rates shown are a typical set of values from three different experiments with similar results
ATP hydrolysis has been measured using phenol red as indicated in Materials and Methods.
ATP hydrolysis has been measured in the presence of 0.3% LDAO. Rates are given in μmol/min/mg.
The fold increase, shown in parentheses, is the ratio of the rate of ATP hydrolysis in the presence of 0.3% LDAO to the rate in the absence of LDAO.
Membrane vesicles were diluted 5-fold with buffer and incubated with 50 μM DCCD for 30 min at room temperature before assay, as described previously [20]. For the double and triple mutants it should be noted that the DCCD-inhibited rates were never significantly different from the similarly-treated controls.